0:00
NaN:NaN:NaN
FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer.
Released July 28, 2017
Flere episoder fra "FDA Drug Information Updates"
Gå ikke glip af nogen episoder af “FDA Drug Information Updates” - abonnér på podcasten med gratisapp GetPodcast.